Biopharmaceutical CDMO ProBioGen has redesigned its website to improve its accessibility.
The new platform has been optimised to deliver an intuitive experience to users, while also facilitating the rapid access of key information.
It also allows customers to easily explore ProBioGen's portfolio of services — including process/analytical development, GMP maufacturing, cell line development, cell banking and advanced solutions for proteins, viral vectors and vaccines.
According to the company, the key benefits of the new website are:
- Its comprehensive insights: The new website includes detailed descriptions of ProBioGen's portfolio, as well as access to white papers and scientific studies. Users can also access industry updates, allowing them to make informed decisions on their projects
- Streamlined navigation: There are now dedicated sections detailing the company's CDMO services and technologies, as well as news, resources and company information.
Chief Business Officer at ProBioGen, Gabriele Schneider, commented: "Our relaunched website reflects ProBioGen's commitment to innovation and partnership putting our customers first,"
"By focusing on clarity and ease of use, the platform empowers visitors to make faster decisions, plan projects more effectively, and drive innovation in next-generation therapies."